CU6
CU6 - HI JAMES, COULD YOU EXPLAIN WHY THE STOCK PRICE FELL BY ABOUT A DOLLAR. IT HAS $123 MILLION CASH IN HAND.
The Latest Q&A
Answer
Hi Indran,
Radio-pharmaceutical stock Clarity Pharmaceuticals (CU6) remains a ~$1.9bn business even after retreating over 16% this week, however, while the company is healthcare growth story its unlikely to make money in the coming years, i.e. its relatively speculative with investors having to decide what price to pay for the potential future earnings – we note the stock is still up ~300% year-to-date.
Put this weeks fall down mixed investor sentiment following recent announcements. While the company highlighted progress in its clinical trials, including the start of a prostate cancer diagnostic product trial, this development coincided with a 10% share price dip at the start of the week. This reaction probably reflects concerns about the timeline for commercial viability or the costs associated with advancing these trials.
